HealthLynked Corp. enhances healthcare through personalized care management that improves outcomes and reduces costs. Its cloud-based platform connects patients with providers for virtual or in-office appointments and consolidates medical records into one secure, accessible location. With AI-driven recommendations, HealthLynked offers tailored insights, streamlines care coordination, and provides savings on prescriptions and medical supplies. NAPLES, Fla., June 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Health ...

LONDON, June 24, 2025 /PRNewswire/ -- Haleon (LSE: HLN) (NYSE: HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025. This appointment follows Franck Riot deciding to leave Haleon after six years in the business. Carl Haney Carl Haney Carl joins Haleon from the Estée Lauder Companies Inc. where he has spent 13 years as Executive Vice President, Global Innovation and Research and Development. Carl previously spent over 20 years at P ...

Prestige Consumer Healthcare (PBH) FY Conference June 11, 2025 10:30 AM ET Speaker0 Good morning, everyone, and thank you for joining us at Oppenheimer's twenty fifth Annual Consumer Growth and Ecommerce Conference. My name is Rupesh Parikh. I'm the senior food, grocery, and consumer products analyst here at Oppenheimer. I'm happy to introduce our next presenting company, Prestige Consumer Healthcare. Joining us today are CEO, Ron Lombardi and VP, IR, and Treasury, Phil Turpolili. Prestige sells and distrib ...

Core Insights - General Mills is facing significant challenges in the current consumer environment, with consumer sentiment at a low point, comparable to the period immediately following the pandemic in 2020 [5][6]. Company Overview - The company is heavily reliant on the U.S. market, with 85% of its business operations based there [6]. - Consumer financial stress is evident, as U.S. consumer debt has increased, indicating that while consumers are still making purchases, they are financially stretched [6]. Industry Context - The overall consumer sentiment in the U.S. is reported to be the second lowest in history, as per the University of Michigan's polling data [6].

The Clorox Company (NYSE:CLX) dbAccess Global Consumer Conference June 4, 2025 6:00 AM ET Company Participants Linda J. Rendle - CEO & Chairman Luc Bellet - Executive VP & CFO Conference Call Participants Stephen Robert R. Powers - Deutsche Bank AG, Research Division Stephen Robert R. Powers With us today, Chair and Chief Executive Officer, Linda Rendle. Welcome back, Linda. And for the first time as Chief Financial Officer with us today is Luc Bellet. So Luc, welcome, and thanks for joining us. Great. So w ...

Group 1: Investment and Strategy - CVS Health plans to invest $20 billion over the next 10 years to create a "tech-enabled consumer health experience" that integrates its businesses and allows competitors to participate [1] - Advancing digital strategies is one of four priorities for CVS Health by 2025, with a focus on enhancing customer experience through a newly designed app [5] Group 2: Interoperability and Consumer Experience - The project aims to establish interoperability in the healthcare sector, allowing different players to communicate through a single patient record, addressing the primary complaint of customers regarding lack of integration [2][4] - The proposed solution may include a dashboard for healthcare providers to view a comprehensive picture of a patient's healthcare journey, rather than isolated visits or prescriptions [3] Group 3: Consumer Insights and Challenges - A report indicates that 18% of consumers find selecting healthcare professionals and asking questions problematic, while 15% struggle to obtain accurate cost estimates for appointments [4] - There is significant interest among consumers in using patient portals, with 32% expressing strong interest if offered by their providers [4]

Financial Data and Key Metrics Changes - The company acknowledged that its absolute performance in the quarter was unsatisfactory, but it managed to hold unit share in a category that faced greater than expected declines [4] - The EBITDA margin guidance was down about 30 to 40 basis points from prior expectations, primarily due to category trends impacting gross margin and tariffs affecting input costs [28][29] Business Line Data and Key Metrics Changes - The company is focusing on innovation and targeting faster-growing categories to mitigate weaknesses in the core packaged bread category [4][5] - The Wondercake innovation is pacing ahead of expectations in distribution and has contributed to unit share gains, although it is still early to determine its overall impact on the legacy cake business [14][15] Market Data and Key Metrics Changes - The away-from-home segment continues to experience weakness in overall foodservice sales, but profitability and margins have improved due to restructuring efforts [50] - Private label market share has marginally reversed its downward trend, with a slight increase of about 10 basis points in the last quarter [51] Company Strategy and Development Direction - The company aims to align its portfolio with evolving consumer tastes and invest in on-trend innovation to drive sustainable growth over the long term [4][5] - The company plans to address the shift towards healthier eating by continuing to innovate and differentiate its offerings, particularly in the health and wellness segment [24][25] Management's Comments on Operating Environment and Future Outlook - Management expressed that the current economic environment is challenging, making it difficult to forecast improvements in the near term, with a focus shifting towards 2026 for potential recovery [10][12] - The company remains confident in its long-term financial targets and strategies, despite acknowledging that the current situation may delay achieving those targets [30] Other Important Information - The company is undergoing supply chain optimization, which includes closing an older bakery that produced fresh bread, buns, and rolls [53] - The introduction of smaller product sizes is aimed at addressing consumer needs for convenience and value, with early returns being positive [55] Q&A Session Summary Question: Insights on the core packaged bread category and stabilization - Management indicated that the environment remains dynamic and challenging, with expectations for stabilization possibly extending into 2026 [8][10] Question: Details on the Wondercake innovation's impact - Management noted that it is too early to determine the full impact of Wondercake on the legacy cake business, but initial results are promising [14][15] Question: Changes in promotional strategy and consumer behavior - Management confirmed an increase in promotional activity for differentiated offerings, particularly Dave's Killer Bread, while emphasizing a cautious approach to avoid devaluing the brand [20][22] Question: Addressing structural headwinds in the bread category - Management acknowledged the challenges posed by a shift towards healthier eating and indicated plans to innovate in response to these trends [24][25] Question: Insights on private label and away-from-home business performance - Management reported continued weakness in foodservice sales but noted improvements in profitability due to restructuring efforts, while private label market share has shown slight recovery [50][51]

Core Insights - Hydreight Technologies Inc. has reported significant growth in its financial performance for the fiscal year 2024, achieving record revenues and positive Adjusted EBITDA, while focusing on scaling its VSDHOne platform for 2025 [2][6][9]. Financial Performance - The company achieved record topline revenue of CAD 22.32 million in 2024, representing a 31% increase from 2023 [6][17]. - GAAP revenue for 2024 was CAD 16.04 million, up 39% from CAD 11.51 million in 2023 [6][9]. - Adjusted EBITDA for 2024 was CAD 490,000, a turnaround from a loss of CAD 1.38 million in 2023 [6][17]. - The gross margin for 2024 was CAD 5.75 million, an increase of 8% from the previous year [6][17]. - The fourth quarter of 2024 saw revenues of CAD 4.04 million, a 20% increase compared to the same quarter in 2023 [7][9]. Strategic Focus for 2025 - The company plans to expand franchise white-label partnerships to enhance its market presence [13]. - There is a focus on increasing pharmacy margins through supply chain optimization and strategic pricing [14]. - New wellness categories will be launched, including NAD+, testosterone replacement therapy, and peptide therapies [14]. - The onboarding of high-growth D2C healthcare companies on the VSDHOne platform will be accelerated [15]. - The company aims to attract and support more licensed nurses to enhance its provider network [15]. - Strategic tuck-in acquisitions of complementary D2C health brands are being pursued to improve product mix and margins [15]. Recognition and Milestones - Hydreight was ranked 9 on Deloitte's 2024 Technology Fast 50 list and 56 on the Technology Fast 500 list for North America [6][9]. - The company completed its first post-IPO financing, raising CAD 5.4 million in February 2025 to support its growth initiatives [6][9]. Operational Highlights - The company operates a network of over 3,000 nurses and 200+ physicians across all 50 states, facilitating a scalable telehealth and at-home care model [11][12]. - Hydreight's VSDHOne platform supports over 400 Direct to Consumer license holders, enabling rapid entry into the online healthcare space [11][21].

Sanofi and CD&R close Opella transaction, create global consumer healthcare leader Paris, April 30, 2025. Opella today becomes an independent global leader in consumer healthcare, marking a pivotal step in Sanofi's strategy. Sanofi announces today the closing of the sale to CD&R of a 50.0% controlling stake of its consumer healthcare business Opella. Sanofi retains a significant shareholding of Opella with a 48.2% stake. Bpifrance will own a 1.8% stake in Opella and will join the Board. The transaction was ...